Urinary Excretion of Catecholamines and Their Metabolites in Relation to Circulating Catecholamines: Six-Hour Infusion of Epinephrine and Norepinephrine in Healthy Volunteers

Archives of General Psychiatry

Volumn 49, Issue 7, 1992, Pages 568-572

  Moleman, Peter ^a,b   Tulen, Joke H M ^a   Blankestijn, Peter J ^a   Man'Veld, Arie J ^a   Boomsma, Frans ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Department of Internal Medicine University Hospital Rotterdam Dijkzigt Medical Faculty of Erasmus University Rotterdam ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; ADRENALIN; NORADRENALIN; NORMETADRENALIN; PLACEBO; VANILMANDELIC ACID;

ADRENAL GLAND; ADRENERGIC SYSTEM; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE EXCRETION; CATECHOLAMINE METABOLISM; CATECHOLAMINE RELEASE; CATECHOLAMINE URINE LEVEL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INFUSION; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; EPINEPHRINE; HUMAN; INFUSIONS, INTRAVENOUS; MALE; METHOXYHYDROXYPHENYLGLYCOL; NOREPINEPHRINE; NORMETANEPHRINE; PLACEBOS; SUPPORT, NON-U.S. GOV'T; VANILMANDELIC ACID;

EID: 0026651663     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1992.01820070062009     Document Type: Article

References (37)

1. Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry. 1965;122: 509–522.
2. Maas JW, Fawcett J, DeKirmenjian H. 3-Methoxy-4-hydroxyphenylglycol (MHPG) excretion in depressive states. Arch Gen Psychiatry. 1968;19: 129–134.
3. De Leon-Jones F, Maas JW, DeKirmenjian H, Sanchez J. Diagnostic subgroups of affective disorders and their urinary excretion of catecholamine metabolites. Am J Psychiatry. 1975;132: 1141–1148.
4. Schildkraut JJ, Orsulak PJ, Schatzberg AF, Gudeman JE, Cole JO, Rohde WA, La Brie RA. Toward a biochemical classification of depressive disorders, I: differences in urinary MHPG and other catecholamine metabolites in clinically defined subtypes of depressions. Arch Gen Psychiatry. 1978;35: 1427–1433.
5. Schildkraut JJ, Orsulak PJ, La Brie RA, Schatzberg AF, Gudeman JE, Cole JO, Rohde WA. Toward a biochemical classification of depressive disorders, II: application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites. Arch Gen Psychiatry. 1978;35: 1436–1439.
6. Beckmann H, Goodwin FK. Urinary MHPG in subgroups of depressed patients and normal controls. Neuropsychobiology. 1980;6: 91–100.
7. Agren H. Depressive symptom patterns and urinary MHPG excretion. Psychiatry Res. 1982;6: 185–196.
8. Lake CR, Pickar D, Ziegler MG, Lipper S, Slater S, Murphy DL. High plasma norepinephrine levels in patients with major affective disorder. Am J Psychiatry. 1982;139: 1315–1318.
9. Esler M, Turbott J, Schwarz R, Leonard P, Bobik A, Slews H, Jackman G. The peripheral kinetics of norepinephrine in depressive illness. Arch Gen Psychiatry. 1982;39: 295–300.
10. Koslow SH, Maas JW, Bowden CL, Davis JM, Hamin I, Javaid J. Cerebrospinal fluid and urinary biogenic amines and metabolites in depression and mania: a controlled univariate analysis. Arch Gen Psychiatry. 1983;40: 999–1010.
11. Muscettola G, Potter WZ, Pickar D, Goodwin FK. Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. Arch Gen Psychiatry. 1984;41: 337–342.
12. Roy A, Pickar D, Linnoila M, Potter WZ. Plasma norepinephrine levels in affective disorders. Arch Gen Psychiatry. 1985;42: 1181–1185.
13. Maas JW, Koslow SH, Davis JM, Katz M, Frazer A, Bowden CL, Berman H, Gibbons R, Stokes P, Landis H. Catecholamine metabolism and disposition in healthy and depressed subjects. Arch Gen Psychitry. 1987;44: 337–344.
14. Roy A, Pickar D, DeJong J, Karoum F, Linnoila M. Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Arch Gen Psychiatry. 1988;45: 849–857.
15. Davis JM, Koslow SH, Gibbons RD, Maas JW, Bowden CL, Casper R, Hamin I, Javaid JI, Chang SS, Stokes PE. Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls. Arch Gen Psychiatry. 1988;45: 705–717.
16. Schatzberg AF, Samson JA, Bloomingdale KL, Orsulak PJ, Gerson B, Kizuka PP, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders, X: urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders. Arch Gen Psychiatry. 1989;46: 260–268.
17. Linnoila M, Oliver J, Adrinoff B, Potter WZ. High correlations of norepinephrine, dopamine, and epinephrine and their major metabolite excretion rates. Arch Gen Psychiatry. 1988;45: 701–704.
18. Roy A, Guthrie S, Karoum F, Pickar D, Linnoila M. High intercorrelations among urinary outputs of norepinephrine and its major metabolites. Arch Gen Psychiatry. 1988;45: 158–161.
19. Siever LJ, Uhde TW, Jimerson DC, Lakde CR, Kopin IJ, Murphy DL. Indices of noradrenergic output in depressions. Psychiatry Res. 1986;19: 59–73.
20. Kopin IJ. Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev. 1985;37: 333–364.
21. Kopin IJ, Polinsky RJ, Oliver JA, Oddershede IR, Ebert MH. Urinary catecholamine metabolites distinguish different types of sympathetic neuronal dysfunction in patients with orthostatic hypotension. J Clin Endocrinol Metab. 1983;57: 632–637.
22. Maas JW, Landis DH. The metabolism of circulating norepinephrine by human subjects. J Pharmacol Exp Ther. 1971;177: 600–612.
23. Nuttin J, Beuten B. Handleiding bij depersoonlijkheidsinventaris MMPI. Leuven, Belgium: Leuvense Universiteit Uitgaven; 1969.
24. Van der Ploeg HM, Defares PB, Spielberger CD. ZBVHandleiding bij de Zelf-Beoordelings Vragenlijst. Lisse, the Netherlands: Swets & Zeitlinger; 1980.
25. Van der Hoorn FAJ, Boomsma F, Man in 't Veld AJ, Schalekamp MADH. Determination of plasma catecholamines by high-performance liquid chromatography: comparison between a new method with fluorescence detection and an established method with electrochemical detection. J Chromatogr. 1989;487: 17–28.
26. Moleman P. Preservation of urine samples for assay of catecholamines and their metabolites. Clin Chem. 1985;31: 653–654.
27. Moleman P, Borstrok JJM. Analysis of urinary 3-methoxy-4-hydroxyphenylglycol by high-performance liquid chromatography and electrochemical detection. J Chromatogr. 1982;227: 391–405.
28. Moleman P, Borstrok JJM. Determination of urinary vanillylmandelic acid by liquid chromatography with electrochemical detection. Clin Chem. 1983;29: 878–881.
29. Moleman P, Van Dijk J. Determination of urinary norepinephrine and epinephrine by liquid chromatography with fluorescence detection and precolumn derivatization. Clin Chem. 1990;36: 732–736.
30. Dimsdale JE, Moss J. Short-term catecholamine response to psychological stress. Psychosom Med. 1980;42: 493–497.
31. Halter JB, Stratton JR, Pfeifer MA. Plasma catecholamines and hemodynamic responses to stress states in man. Acta Physiol Scand. 1984;527(suppl): 31–38.
32. Stratton JR, Pfeifer MA, Ritchie JL, Halter JB. Hemodynamic effects of epinephrine: concentration-effect study in humans. J Appl Physiol. 1985;58: 1199–1206.
33. Blankestijn PJ, Man in 't Veld AJ, Tulen J, van den Meiracker AH, Boomsma F, Moleman P, Ritsema van Eck HJ, Derkx FHM, Mulder P, Lamberts SJ, Schalekamp MADH. Support for adrenaline-hypertension hypothesis: 18 hour pressor effect after 6 hours adrenaline infusion. Lancet. 1988;2: 1386–1389.
34. Tulen JHM, Moleman P, Blankestijn PJ, Man in 't Veld AJ, van Steenis HG, Boomsma F. Cardiovascular, endocrine, and psychological changes during six hours of continuous infusion of epinephrine or norepinephrine in healthy volunteers. Psychosom Med. In press.
35. Hjemdahl P, Sjöquist B, Daleskog M, Eliasson K. A comparison of noradrenaline, MHPG and VMA in plasma as indicators of sympathetic nerve activity in man. Acta Physiol Scand. 1982;115: 507–509.
36. Schalekamp MADH, Vincent HH, Man in 't Veld AJ. Adrenaline, stress, and hypertension. Lancet. 1983;1;362.
37. Musgrave IF, Bachmann AW, Jackson RV, Gordon RD. Increased plasma noradrenaline during low dose adrenaline infusion in resting man and during sympathetic stimulation. Clin Exp Pharmacol Physiol. 1985;12: 285–289.